Cargando…
OA06.04 Immune Response after SARS-CoV-2 Vaccination in Lung Cancer Patients. Update of the Covid Lung Vaccine Cohort
Autores principales: | Hernandez, A., Notario, L., Quirant, B., Felip, E., Boigues, M., Saigí, M., Cucurull, M., Torres, P., Martinez, M.J., Castella, R. Gomez, Esteban, M. Rodriguez, Martin, M. Benitez, Carcereny, E., Domenech, M., Estival, A., Pous, A., López-Paradís, A., Romeo, M., Moran, T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452014/ http://dx.doi.org/10.1016/j.jtho.2022.07.036 |
Ejemplares similares
-
1591P Immune response after vaccination against SARS-COV-2 in lung cancer (LC) patients (p). Prospective study in the Medical Oncology Department at the Catalan Institute of Oncology-Badalona, Spain: COVID-lung vaccine
por: Felip, E., et al.
Publicado: (2021) -
OA06.03 Serological Response to SARS-CoV-2 Vaccination in Patients Lung Cancer: A Mount Sinai-Led Prospective Matched Controlled Study
por: Mack, P.C., et al.
Publicado: (2022) -
Immune Response and Effects of COVID-19 Vaccination in Patients with Lung Cancer—COVID Lung Vaccine Study
por: Hernandez, Ainhoa, et al.
Publicado: (2022) -
OA06.05 Impact of COVID-19 Pandemic on Proportion and Treatment Patterns for Stage I Non-small Cell Lung Cancer in the Netherlands
por: Wolfhagen, N., et al.
Publicado: (2022) -
OA06.07 Stereotactic Ablative Radiotherapy Before Resection to AvoId Delay for Early-Stage LunG Cancer or OligomEts
por: Kidane, B., et al.
Publicado: (2022)